• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORPORATION GEL-ONE X-LINKED HYALUR 3ML; BIOLOGICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORPORATION GEL-ONE X-LINKED HYALUR 3ML; BIOLOGICS Back to Search Results
Model Number 00-1111-001-00
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Dyspnea (1816); Erythema (1840); Fatigue (1849); Itching Sensation (1943); Nausea (1970); Pain (1994); Vomiting (2144); Dizziness (2194); Shaking/Tremors (2515); Ambulation Difficulties (2544); Swelling/ Edema (4577); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 02/28/2022
Event Type  Injury  
Event Description
It was reported that the patient had a gel-one injection on the right knee.Subsequently, the patient experienced swelling, stiffness, pain, difficulty walking, hives, severe itching and redness of the trunk, fatigue, nausea, vomiting, dizziness, tremors, fainting, and dyspnea.Patient was prescribed methylprednisolone and took over the counter benadryl.No additional patient consequences were reported.
 
Event Description
No additional event information is available at the time of this report.
 
Event Description
It was reported patient had gel one injection in right knee.Within one hour patient started having allergic reaction symptoms with itching, and hives.Patient self-medicated with benadryl which reduced the swelling and itching.Patient later had an episode of syncope, nausea or vomiting.Prescription for medrol pack prescribed.Due to time constraints of acquiring the prescription, symptoms exacerbated to swollen lips and hoarseness.After taking medrol dose, within an hour started feeling normal with exception of not able to sleep due to steroid use resulting in fatigue.No additional patient consequences were reported at the time of this report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GEL-ONE X-LINKED HYALUR 3ML
Type of Device
BIOLOGICS
Manufacturer (Section D)
SEIKAGAKU CORPORATION
6-1, marunouchi
1-chrome chiyoda-ku, tokyo
MDR Report Key14717908
MDR Text Key294903883
Report Number0001822565-2022-01720
Device Sequence Number1
Product Code MOZ
UDI-Device Identifier04987541300911
UDI-Public(01)04987541300911(17)231107(10)0021J07G
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 08/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/16/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/07/2023
Device Model Number00-1111-001-00
Device Catalogue Number00111100100
Device Lot Number0021J07G
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date07/27/2022
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberN/A
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
-
-